We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Diabetes Care at Austrian GPs (DCA09)

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00979394
First Posted: September 18, 2009
Last Update Posted: August 17, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Bristol-Myers Squibb
Information provided by:
AstraZeneca
September 17, 2009
September 18, 2009
August 17, 2010
October 2009
January 2010   (Final data collection date for primary outcome measure)
Evaluate characteristics or co morbidities being existent for patient with T2D at GP [ Time Frame: Once per patient ]
Same as current
Complete list of historical versions of study NCT00979394 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation of Diabetes Care at Austrian GPs
Diabetes Care Austria 2009

This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:

  • To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,
  • To evaluate representative profile of patient with T2D in Austria,
  • To evaluate which medical therapies are used.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
GPs
Type 2 Diabetes
Not Provided
Patients with type 2 diabetes
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
1513
January 2010
January 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diabetes mellitus type II

Exclusion Criteria:

  • Diabetes mellitus type I
  • Gestation diabetes
  • Induced diabetes
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00979394
NIS-CAT-DUM-2009/1
No
Not Provided
Not Provided
MC MD, AstraZeneca
AstraZeneca
Bristol-Myers Squibb
Study Chair: Bernhard Ludvig General Hospital Vienna
Study Chair: Guntram Schernthaner Krankenanstalt Rudolfsstiftung
AstraZeneca
August 2010